Chen Shmuel, Chau Katherine H, Nazif Tamim M
Columbia University Irving Medical Center/New York-Presbyterian Hospital, New York, NY, USA.
Ann Cardiothorac Surg. 2020 Nov;9(6):452-467. doi: 10.21037/acs-2020-av-23.
Transcatheter aortic valve replacement (TAVR) has developed into an established therapy for patients with severe aortic stenosis (AS) across the spectrum of surgical risk. Despite improvements in transcatheter heart valve (THV) technologies and procedural techniques, cardiac conduction disturbances, including high degree atrioventricular block (AVB) requiring permanent pacemaker (PPM) implantation and new-onset left bundle branch block (LBBB), remain frequent complications. TAVR-related conduction disturbances occur due to injury to the conduction system from interactions with interventional equipment and the transcatheter valve stent frame. Risk factors for post-TAVR conduction disturbances have been identified and include clinical characteristics, baseline electrocardiogram findings (right bundle branch block), anatomic factors, and potentially modifiable procedural factors (type of transcatheter valve, depth of implantation, over-sizing). New-onset LBBB and PPM implantation after TAVR have been shown to be associated with adverse long-term clinical outcomes, including mortality and heart failure hospitalization. These clinical consequences are likely to be of increasing importance as TAVR is utilized in younger and lower risk population. This review provides an updated overview of the literature regarding the incidence, predictors, and clinical outcomes of TAVR-related conduction disturbances, as well as proposed strategies for the management of this frequent clinical challenge.
经导管主动脉瓣置换术(TAVR)已发展成为一种针对不同手术风险的重度主动脉瓣狭窄(AS)患者的成熟治疗方法。尽管经导管心脏瓣膜(THV)技术和手术操作技术有所改进,但心脏传导障碍,包括需要植入永久起搏器(PPM)的高度房室传导阻滞(AVB)和新发左束支传导阻滞(LBBB),仍然是常见的并发症。TAVR相关的传导障碍是由于介入设备和经导管瓣膜支架框架相互作用对传导系统造成损伤所致。已确定TAVR后传导障碍的危险因素,包括临床特征、基线心电图表现(右束支传导阻滞)、解剖因素以及可能可改变的手术因素(经导管瓣膜类型、植入深度、尺寸过大)。TAVR后新发LBBB和PPM植入已被证明与不良的长期临床结局相关,包括死亡率和心力衰竭住院率。随着TAVR应用于更年轻、风险更低的人群,这些临床后果可能会变得越来越重要。本综述提供了关于TAVR相关传导障碍的发生率、预测因素和临床结局的文献最新概述,以及针对这一常见临床挑战的管理建议策略。